share_log

完美醫療:截至二零二四年三月三十一日止年度的末期股息

PERFECT MEDICAL: FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2024

HKEX ·  Jun 28 12:03

Summary by Futu AI

完美醫療健康管理有限公司(股份代號:01830)於2024年6月28日宣布,將為截至2024年3月31日止年度派發末期普通股息每股0.119港元。股東批准日期定於2024年8月9日,而股息除淨日為2024年8月15日。股份過戶登記將於2024年8月19日至2024年8月22日暫停,記錄日期為2024年8月22日。股息派發日訂於2024年9月6日。該公司董事會成員包括執行董事歐陽江醫生、歐陽慧女士、歐陽虹女士及蘇顯龍先生,以及獨立非執行董事徐慧敏女士、曹依萍女士及季志雄先生。
完美醫療健康管理有限公司(股份代號:01830)於2024年6月28日宣布,將為截至2024年3月31日止年度派發末期普通股息每股0.119港元。股東批准日期定於2024年8月9日,而股息除淨日為2024年8月15日。股份過戶登記將於2024年8月19日至2024年8月22日暫停,記錄日期為2024年8月22日。股息派發日訂於2024年9月6日。該公司董事會成員包括執行董事歐陽江醫生、歐陽慧女士、歐陽虹女士及蘇顯龍先生,以及獨立非執行董事徐慧敏女士、曹依萍女士及季志雄先生。
Perfect Medical Health Management Limited (stock code: 01830) announced on June 28, 2024 that it will distribute a final ordinary dividend of HK$0.119 per share for the year ending March 31, 2024. The shareholder approval date is set for August 9, 2024, and the ex-dividend date is August 15, 2024. The share transfer registration will be suspended from August 19, 2024 to August 22, 2024, and the record date is August 22, 2024. The dividend payment date is scheduled for September 6, 2024. The board of directors of the company includes executive directors Dr. Ouyang Jiang, Ms. Ouyang Hui, Ms. Ouyang Hong, and Mr. Su Xianlong, as well as independent non-executive directors Ms. Xu Huimin, Ms. Cao Yiping, and Mr. Ji Zhixiong.
Perfect Medical Health Management Limited (stock code: 01830) announced on June 28, 2024 that it will distribute a final ordinary dividend of HK$0.119 per share for the year ending March 31, 2024. The shareholder approval date is set for August 9, 2024, and the ex-dividend date is August 15, 2024. The share transfer registration will be suspended from August 19, 2024 to August 22, 2024, and the record date is August 22, 2024. The dividend payment date is scheduled for September 6, 2024. The board of directors of the company includes executive directors Dr. Ouyang Jiang, Ms. Ouyang Hui, Ms. Ouyang Hong, and Mr. Su Xianlong, as well as independent non-executive directors Ms. Xu Huimin, Ms. Cao Yiping, and Mr. Ji Zhixiong.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.